![Joan Connolly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Joan Connolly
Directeur Technique/Scientifique/R&D chez
ENGENE THERAPEUTICS INC.
Fortune : - $ au 30/06/2026
Profil
Joan Connolly is currently Chief Technology Officer at enGene Therapeutics, Inc. since 2024.
Formerly, Ms. Connolly was Chief Technology Officer at Albireo Pharma, Inc. from 2021 to 2023 and Senior Vice President-Technical Operations at Stemline Therapeutics, Inc. Education includes an undergraduate degree from Queen's University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 16/06/2026 | 0 ( -.--% ) | - $ | 30/06/2026 |
Postes actifs de Joan Connolly
| Sociétés | Poste | Début |
|---|---|---|
| ENGENE THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 21/10/2024 |
Anciens postes connus de Joan Connolly
| Sociétés | Poste | Fin |
|---|---|---|
| ALBIREO PHARMA, INC. | Directeur Technique/Scientifique/R&D | 01/01/2023 |
| STEMLINE THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Joan Connolly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
4
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stemline Therapeutics, Inc.
 Stemline Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes novel oncology therapeutics | Health Technology |
Queen's University
 Queen's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Albireo Pharma, Inc.
 Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
enGene Holdings, Inc.
 enGene Holdings, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a clinical-stage biotechnology company that develops, manufactures and sells non-viral genetic medicines | Commercial Services |
Choisissez Zonebourse 
